Home›People›Isaac Chan
Isaac Chan

Isaac Chan

Chief Scientific Officer, Co-founder and director at InterAct Therapeutics.

Director
Updated Nov 10, 2026·Latest SEC filing Jul 21, 2026·Suggest an edit

About Isaac Chan

Isaac Chan is a chief scientific officer, co-founder and director at InterAct Therapeutics.

Experience

This experience comes from Isaac Chan's profile and from SEC filings. For roles taken from filings, the years are when the filings name Isaac Chan in the role, so the role may have started earlier or lasted longer.

InterAct Therapeutics, Inc. Current
Chief Scientific Officer, Co-founder and director
Co-Founder, Chief Scientific Officer (2025 – Present)
2025 – Present · Dallas, TX
Develops gene therapies for people with metastatic cancer, starting with breast cancer in the liver.
University of Texas Southwestern Medical Center Current
Assistant Professor
2020 – Present
The Johns Hopkins University School of Medicine
Medical Oncology Fellow
2016 – 2020
Boston University School of Medicine
Resident
2015 – 2016

Key Colleagues at Startups

The people Isaac Chan works with at each company, as listed on that company's latest Form D.

InterAct Therapeutics, Inc. · Form D, Jul 21, 2026
Daniel Hargrove
Daniel Hargrove
Chief Executive Officer, Co-founder and director

Sources

  1. SECInterAct Therapeutics, Inc. Form D, filed Jul 21, 2026